Changing paradigms in the management of deep vein thrombosis

British Journal of Haematology

Volumn 170, Issue 2, 2015, Pages 162-174

  Lang, Kathryn J ^a   Saha, Prakash ^b   Roberts, Lara N ^a   Arya, Roopen ^a  

^a KING'S COLLEGE HOSPITAL NHS FOUNDATION TRUST   (United Kingdom)

^b GUY S HOSPITAL   (United Kingdom)

Author keywords

Anticoagulation; Deep vein thrombosis; Non vitamin K antagonist oral anticoagulant(s); Post thrombotic syndrome; Thrombolysis

Indexed keywords

ALGORITHM; DIAGNOSTIC IMAGING; DISEASE MANAGEMENT; HUMAN; OUTCOME ASSESSMENT; PROCEDURES; PROGNOSIS; VENOUS THROMBOSIS;

ALGORITHMS; DIAGNOSTIC IMAGING; DISEASE MANAGEMENT; HUMANS; OUTCOME ASSESSMENT (HEALTH CARE); PROGNOSIS; VENOUS THROMBOSIS;

EID: 84934442866     PISSN: 00071048     EISSN: 13652141     Source Type: Journal    
DOI: 10.1111/bjh.13431     Document Type: Review

References (110)

1. Agnelli, G., Buller, H., Cohen, A., Curto, M., Gallus, A., Johnson, M., Masiukiewicz, U., Pak, R., Thompson, J., Raskob, G. & Weitz, J. (2013) Oral apixaban for the treatment of acute venous thromboembolism. The New England Journal of Medicine, 369, 799-808.
2. Alotaibi, G., Almodaimegh, H., McMurtry, M. & Wu, C. (2013) Do women bleed more than men when prescribed novel oral anticoagulants for venous thromboembolism? A sex-based meta-analysis. Thrombosis Research, 132, 185-189.
3. Andia, M., Saha, P., Jenkins, J., Modarai, B., Wiethoff, A., Phinikaridou, A., Grover, S., Patel, A., Schaeffter, T., Smith, A. & Botnar, R. (2014) Fibrin-targeted magnetic resonance imaging allows in vivo quantification of thrombus fibrin content and identifies thrombi amenable for thrombolysis. Arteriosclerosis, Thrombosis, and Vascular Biology, 34, 1193-1198.
4. Aziz, F. & Comerota, A. (2012) Quantity of residual thrombus after successful catheter-directed thrombolysis for iliofemoral deep venous thrombosis correlates with recurrence. European Journal of Vascular and Endovascular Surgery, 44, 210-213.
5. Baekgaard, N., Broholm, R., Just, S., Jørgensen, M. & Jensen, L. (2010) Long-term results using catheter-directed thrombolysis in 103 lower limbs with acute iliofemoral venous thrombosis. European Journal of Vascular and Endovascular Surgery, 39, 112-117.
6. Baglin, T., Douketis, J., Tosetto, A., Marcucci, M., Cushman, M., Kyrle, P., Palareti, G., Poli, D., Tait, R. & Iorio, A. (2010a) Does the clinical presentation and extent of venous thrombosis predict likelihood and type of recurrence? A patient-level meta-analysis. Journal of Thrombosis and Haemostasis, 8, 2436-2442.
7. Baglin, T., Gray, E., Greaves, M., Hunt, B., Keeling, D., MacHin, S., MacKie, I., Makris, M., Nokes, T., Perry, D., Tait, R., Walker, I. & Watson, H. (2010b) Clinical guidelines for testing for heritable thrombophilia. British Journal of Haematology, 149, 209-220.
8. Bashir, R., Zack, C., Zhao, H., Comerota, A. & Bove, A. (2014) Comparative outcomes of catheter-directed thrombolysis plus anticoagulation vs anticoagulation alone to treat lower-extremity proximal deep vein thrombosis. JAMA Internal Medicine, 174, 1494-1501.
9. Bates, S., Jaeschke, R., Stevens, S., Goodacre, S., Wells, P., Stevenson, M., Kearon, C., Schunemann, H., Crowther, M., Pauker, S., Makdissi, R. & Guyatt, G. (2012) Diagnosis of DVT: antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest, 141, e351S-e418S.
10. Bauersachs, R., Berkowitz, S., Brenner, B. & Buller, H. (2010a) Oral rivaroxaban for symptomatic venous thromboembolism. The New England Journal of Medicine, 363, 2499-2510.
11. Bauersachs, R., Berkowitz, S., Brenner, B., Buller, H., Gallus, A., Anthonie, W., Misselwitz, F., Prins, M., Raskob, G., Segers, A., Wells, P., Bounameaux, H., Cohen, A., Bruce, L., Piovella, F. & Schellong, S. (2010b) Oral rivaroxaban for symptomatic venous thromboembolism. New England Journal of Medicine, 363, 2499-2510.
12. Becattini, C., Agnelli, G., Schenone, A., Eichinger, S., Bucherini, E., Silingardi, M., Bianchi, M., Moia, M., Ageno, W., Vandelli, M., Grandone, E. & Prandoni, P. (2012) Aspirin for preventing the recurrence of venous thromboembolism. The New England Journal of Medicine, 366, 1959-1967.
13. Beyth, R., Cohen, A. & Landefeld, S. (1995) Long-term outcomes of deep-vein thrombosis. Archives of Internal Medicine, 155, 1031-1037.
14. Bouchard, J., Ghannoum, M., Bernier-Jean, A., Williamson, D., Kershaw, G., Weatherburn, C., Eris, J., Tran, H., Patel, J. & Roberts, D. (2015) Comparison of intermittent and continuous extracorporeal treatments for the enhanced elimination of dabigatran. Clinical Toxicology, 53, 156-163.
15. Bouman, A., Cheung, Y., Spronk, H., Schalkwijk, C., ten Cate, H., ten Wolde, M. & ten Cate-Hoek, A. (2014) Biomarkers for post thrombotic syndrome: a case-control study. Thrombosis Research, 134, 369-375.
16. Brighton, T., Eikelboom, J., Mann, K., Mister, R., Gallus, A., Ockelford, P., Gibbs, H., Hague, W., Xavier, D., Diaz, R., Kirby, A. & Simes, J. (2012) Low-dose aspirin for preventing recurrent venous thromboembolism. The New England Journal of Medicine, 367, 1979-1987.
17. Buller, H., Cate-hoek, A., Hoes, A., Joore, M., Moons, K. & Oudega, R. (2009) Safely ruling out deep venous thrombosis in primary care. Annals of Internal Medicine, 150, 229-236.
18. Büller, H., Décousus, H., Grosso, M., Mercuri, M., Middeldorp, S., Prins, M., Raskob, G., Schellong, S., Schwocho, L., Segers, A., Shi, M., Verhamme, P. & Wells, P. (2013) Edoxaban versus warfarin for the treatment of symptomatic venous thromboembolism. The New England Journal of Medicine, 369, 1406-1415.
19. Cantwell, C., Cradock, A., Bruzzi, J., Fitzpatrick, P., Eustace, S. & Murray, J. (2006) MR venography with true fast imaging with steady-state precession for suspected lower-limb deep vein thrombosis. Journal of Vascular and Interventional Radiology, 17, 1763-1769.
20. Chandra, E., Ahmadi, M., Bailey, M., Griffin, K., Berridge, D., Coughlin, P. & Scott, D. (2013) Early re-presentations and the potential role of catheter-directed thrombolysis in patients diagnosed with a lower limb deep vein thrombosis: a single-centre experience. Phlebology, 28, 404-408.
21. Chitsike, R., Rodger, M., Kovacs, M., Betancourt, M., Wells, P., Anderson, D., Chagnon, I., LE Gal, G., Solymoss, S., Crowther, M., Perrier, A., White, R., Vickars, L., Ramsay, T. & Kahn, S. (2012) Risk of post-thrombotic syndrome after subtherapeutic warfarin anticoagulation for a first unprovoked deep vein thrombosis: results from the REVERSE study. Journal of Thrombosis and Haemostasis, 10, 2039-2044.
22. Coleman, C., Limone, B., Bookhart, B., Mody, S. & Nutescu, E. (2014) Cost-effectiveness analysis of extended duration anticoagulation with rivaroxaban to prevent recurrent venous thromboembolism. Thrombosis Research, 133, 743-749.
23. Cosmi, B., Legnani, C., Tosetto, A., Pengo, V., Ghirarduzzi, A., Testa, S., Prisco, D., Poli, D., Tripodi, A., Marongiu, F. & Palareti, G. (2010a) Usefulness of repeated D-dimer testing after stopping anticoagulation for a first episode of unprovoked venous thromboembolism: the PROLONG II prospective study. Blood, 115, 481-488.
24. Cosmi, B., Legnani, C., Tosetto, A., Pengo, V., Ghirarduzzi, A., Testa, S., Prisco, D., Poli, D., Tripodi, A. & Palareti, G. (2010b) Comorbidities, alone and in combination with D-dimer, as risk factors for recurrence after a first episode of unprovoked venous thromboembolism in the extended follow-up of the PROLONG study. Thrombosis and Haemostasis, 103, 1152-1160.
25. Cramer, S., Rordorf, G., Maki, J., Kramer, L., Grotta, J., Burgin, W., Hinchey, J., Benesch, C., Furie, K., Lutsep, H., Kelly, E. & Longstreth, W. (2004) Increased pelvic vein thrombi in cryptogenic stroke: results of the Paradoxical Emboli from Large Veins in Ischemic Stroke (PELVIS) study. Stroke, 35, 46-50.
26. De Wolf, M., Wittens, C. & Kahn, S. (2012) Incidence and risk factors of the post-thrombotic syndrome. Phlebology, 27, 85-94.
27. Douketis, J., Crowther, M., Foster, G. & Ginsberg, J. (2001) Does the location of thrombosis determine the risk of disease recurrence in patients with proximal deep vein thrombosis? American Journal of Medicine, 110, 515-519.
28. Douma, R., Tan, M., Schutgens, R., Bates, S., Perrier, A., Legnani, C., Biesma, D., Ginsberg, J., Bounameaux, H., Palareti, G., Carrier, M., Mol, G., Le Gal, G., Kamphuisen, P. & Righini, M. (2012) Using an age-dependent D-dimer cut-off value increases the number of older patients in whom deep vein thrombosis can be safely excluded. Haematologica, 97, 1507-1513.
29. Eerenberg, E., Kamphuisen, P., Sijpkens, M., Meijers, J., Buller, H. & Levi, M. (2011) Reversal of rivaroxaban and dabigatran by prothrombin complex concentrate: a randomized, placebo-controlled, crossover study in healthy subjects. Circulation, 124, 1573-1579.
30. Eichinger, S., Heinze, G. & Kyrle, P. (2014) D-dimer levels over time and the risk of recurrent venous thromboembolism: an update of the Vienna prediction model. Journal of the American Heart Association, 3, e000467.
31. Elsharawy, M. & Elzayat, E. (2002) Early results of thrombolysis vs anticoagulation in iliofemoral venous thrombosis. A randomised clinical trial. European Journal of Vascular and Endovascular Surgery, 24, 209-214.
32. Enden, T., Haig, Y., Kløw, N., Slagsvold, C.-E., Sandvik, L., Ghanima, W., Hafsahl, G., Holme, P., Holmen, L., Njaastad, A., Sandbæk, G. & Sandset, P. (2012) Long-term outcome after additional catheter-directed thrombolysis versus standard treatment for acute iliofemoral deep vein thrombosis (the CaVenT study): a randomised controlled trial. Lancet, 379, 31-38.
33. Fancher, T.L., White, R.H. & Kravitz, R.L. (2004) Combined use of rapid D-dimer testing and estimation of clinical probability in the diagnosis of deep vein thrombosis: systematic review. BMJ, 329, 821.
34. Franzeck, U., Schalch, I., Jäger, K., Schneider, E., Grimm, J. & Bollinger, A. (1996) Prospective 12-year follow-up study of clinical and hemodynamic sequelae after deep vein thrombosis in low-risk patients (Zürich Study). Circulation, 93, 74-79.
35. Franzeck, U., Schalch, I. & Bollinger, A. (1997) On the relationship between changes in the deep veins evaluated by duplex sonography and the postthrombotic syndrome 12 years after deep vein thrombosis. Thrombosis and Haemostasis, 77, 1109-1112.
36. Galanaud, J., Holcroft, C., Rodger, M., Kovacs, M., Betancourt, M., Wells, P., Anderson, D., Chagnon, I., Le Gal, G., Solymoss, S., Crowther, M., Perrier, A., White, R., Vickars, L., Ramsay, T. & Kahn, S. (2013) Predictors of post-thrombotic syndrome in a population with a first deep vein thrombosis and no primary venous insufficiency. Journal of Thrombosis and Haemostasis, 11, 474-480.
37. González-Fajardo, J., Martin-Pedrosa, M., Castrodeza, J., Tamames, S. & Vaquero-Puerta, C. (2008) Effect of the anticoagulant therapy in the incidence of post-thrombotic syndrome and recurrent thromboembolism: comparative study of enoxaparin versus coumarin. Journal of Vascular Surgery, 48, 953-959.
38. Halaby, R., Popma, C., Cohen, A., Chi, G., Zacarkim, M., Romero, G., Goldhaber, S., Hull, R., Hernandez, A., Mentz, R., Harrington, R., Lip, G., Peacock, F., Welker, J., Martin-Loeches, I., Daaboul, Y., Korjian, S. & Gibson, C. (2014) D-dimer elevation and adverse outcomes. Journal of Thrombosis and Thrombolysis, 39, 55-59.
39. Hansson, P.-O., Sörbo, J. & Eriksson, H. (2000) Recurrent venous thromboembolism after deep vein thrombosis. Archives of Internal Medicine, 160, 769-774.
40. Harenberg, J., Merx, K., Hoffmann, U., Tolle, A. & Huisman, M. (2002) Deep venous thrombosis: rate of spontaneous lysis and thrombus extension. International Angiology, 14, 73-78.
41. Heit, J., Silverstein, M., Mohr, D., Petterson, T., O'Fallon, W. & Melton, L. (1999) Predictors of survival after deep vein thrombosis and pulmonary embolism. Archives of Internal Medicine, 159, 445-453.
42. Heit, J., Mohr, D., Silverstein, M., Petterson, T., O'Fallon, W. & Melton, J. (2000) Predictors of recurrence after deep vein thrombosis and pulmonary embolism. Archives of Internal Medicine, 160, 761-768.
43. Ho, W., Hankey, G., Quinlan, D. & Eikelboom, J. (2006) Risk of recurrent venous thromboembolism in patients with common thrombophilia: a systematic review. Archives of Internal Medicine, 166, 729-736.
44. Holster, L., Valkhoff, V., Kuipers, E. & Tjwa, E. (2013) New oral anticoagulants increase risk for gastrointestinal bleeding: a systematic review and meta-analysis. Gastroenterology, 145, e15.
45. Horner, D., Hogg, K., Body, R., Jones, S., Nash, M. & Mackway-Jones, K. (2014) Single whole-leg compression ultrasound for exclusion of deep vein thrombosis in symptomatic ambulatory patients: a prospective observational cohort study. British Journal of Haematology, 164, 422-430.
46. Houshmand, S., Salavati, A., Hess, S., Ravina, M. & Alavi, A. (2014) The role of molecular imaging in diagnosis of deep vein thrombosis. American Journal of Nuclear and Molecular Imaging, 4, 406-425.
47. Huang, S., Kim, C., Miller, M., Gupta, R., Lessne, M., Horvath, J., Boll, D., Evans, P., Befera, N., Krishnan, P., Chan, J. & Merkle, E. (2013) Abdominopelvic and lower extremity deep venous thrombosis: evaluation with contrast-enhanced MR venography with a blood-pool agent. American Journal of Roentgenology, 201, 208-214.
48. Johnson, S., Stevens, S., Woller, S., Lake, E. & Donadini, M. (2010) Risk of deep vein thrombosis following a single negative whole-leg compression ultrasound. Journal of the American Medical Association, 303, 438-445.
49. Kahn, S. (2009) Measurement properties of the Villalta scale to define and classify the severity of the post-thrombotic syndrome. Journal of Thrombosis and Haemostasis, 7, 884-888.
50. Kahn, S. (2011) The post thrombotic syndrome. Thrombosis Research, 127, S89-S92.
51. Kahn, S., Shrier, I., Julian, J., Ducruet, T., Arsenault, L., Roussin, A., Desmarais, S., Joyal, F., Kassis, J., Solymoss, S. & Desjardins, L. (2008) Determinants and time course of the postthrombotic syndrome after acute deep venous thrombosis. Annals of Internal Medicine, 149, 698-707.
52. Kahn, S., Shrier, I., Shapiro, S., Houweling, A., Hirsch, A., Reid, R., Kearon, C., Rabhi, K., Rodger, M., Kovacs, M., Anderson, D. & Wells, P. (2011) Six-month exercise training program to treat post-thrombotic syndrome: a randomized controlled two-centre trial. Canadian Medical Association Journal, 183, 37-44.
53. Kahn, S., Shapiro, S., Ducruet, T., Wells, P., Rodger, M., Kovacs, M., Anderson, D., Tagalakis, V., Morrison, D., Solymoss, S., Miron, M., Yeo, E., Smith, R., Schulman, S., Kassis, J., Kearon, C., Chagnon, I., Wong, T., Demers, C., Hanmiah, R., Kaatz, S., Selby, R., Rathbun, S., Desmarais, S., Opatrny, L., Ortel, T.L., Galanaud, J.P. & Ginsberg, J.S. (2014a) Graduated compression stockings to treat acute leg pain associated with proximal DVT. A randomised controlled trial. Thrombosis and Haemostasis, 112, 1137-1141.
54. Kahn, S., Comerota, A., Cushman, M., Evans, N., Ginsberg, J., Goldenberg, N., Gupta, D., Prandoni, P., Vedantham, S., Walsh, M. & Weitz, J. (2014b) The postthrombotic syndrome: evidence-based prevention, diagnosis, and treatment strategies: a scientific statement from the American Heart Association. Circulation, 130, 1636-1661.
55. Kakkos, S., Kirkilesis, G. & Tsolakis, I. (2014) Efficacy and safety of the new oral anticoagulants dabigatran, rivaroxaban, apixaban, and edoxaban in the treatment and secondary prevention of venous thromboembolism: a systematic review and meta-analysis of phase III trials. European Journal of Vascular and Endovascular Surgery, 48, 565-575.
56. Kang, N. & Sobieraj, D. (2014) Indirect treatment comparison of new oral anticoagulants for the treatment of acute venous thromboembolism. Thrombosis Research, 133, 1145-1151.
57. Kelly, J., Hunt, B. & Moody, A. (2003) Magnetic resonance direct thrombus imaging: a novel technique for imaging venous thromboemboli. Thrombosis and Haemostasis, 89, 77 3-782.
58. Kobberøe Søgaard, K., Schmidt, M., Pedersen, L., Horváth-Puhó, E. & Toft Sørensen, H. (2014) 30-Year mortality after venous thromboembolism: a population-based cohort study. Circulation, 130, 829-836.
59. Kyrle, P. & Eischer, L. (2013) Predicting the risk of recurrent venous thromboembolism. The Austrian study on recurrent venous thromboembolism (AUREC). Hämostaseologie, 33, 201-209.
60. Kyrle, P., Minar, E., Bialonczyk, C., Hirschl, M., Weltermann, A. & Eichinger, S. (2004) The risk of recurrent venous thromboembolism in men and women. The New England Journal of Medicine, 350, 2558-2563.
61. Lip, G., Frison, L., Halperin, J. & Lane, D. (2011) Comparative validation of a novel risk score for predicting bleeding risk in anticoagulated patients with atrial fibrillation: the HAS-BLED (Hypertension, Abnormal Renal/Liver Function, Stroke, Bleeding History or Predisposition, Labile INR, Elderly, Drug). Journal of the American College of Cardiology, 57, 173-180.
62. Locker, T., Goodacre, S., Sampson, F., Webster, A. & Sutton, A. (2006) Meta-analysis of plethysmography and rheography in the diagnosis of deep vein thrombosis. Emergency Medicine Journal, 23, 630-635.
63. Lu, G., DeGuzman, F., Hollenbach, S., Karbarz, M., Abe, K., Lee, G., Luan, P., Hutchaleelaha, A., Inagaki, M., Conley, P., Phillips, D. & Sinha, U. (2013) A specific antidote for reversal of anticoagulation by direct and indirect inhibitors of coagulation factor Xa. Nature Medicine, 19, 446-451.
64. Marder, V., Soulen, R., Atichartakarn, V., Budzynski, A., Parulekar, S., Kim, J., Edward, N., Zahavi, J. & Algazy, K. (1977) Quantitative venographic assessment of deep vein thrombosis in the evaluation of streptokinase and heparin therapy. Journal of Laboratory and Clinical Medicine, 89, 1018-1029.
65. Mo, Y. & Yam, F. (2015) Recent advances in the development of specific antidotes for target-specific oral anticoagulants. Pharmacotherapy, 35, 198-207.
66. Moody, A. (1997) Direct imaging of deep-vein thrombosis with magnetic resonance imaging. Lancet, 350, 1073.
67. Morling, J., Yeoh, S. & Kolbach, D. (2013) Rutosides for prevention of post-thrombotic syndrome. Cochrane Database Systematic Review, 4, CD005625.
68. Naess, I., Christiansen, S., Romundstad, P., Cannegieter, S., Rosendaal, F. & Hammerstrom, J. (2007) Incidence and mortality of venous thrombosis: a population-based study. Journal of Thrombosis and Haemostasis, 5, 692-699.
69. NICE. (2012) Venous thromboembolic diseases: the management of venous thromboembolic diseases and the role of thrombophilia testing. Available at: http://www.nice.org.uk/guidance/cg144/resources/guidance-venous-thromboembolic-diseases-the-management-of-venous-thromboembolic-diseases-and-the-role-of-thrombophilia-testing-pdf [accessed: 16 March 2015].
70. Oger, E. (2000) Incidence of venous thromboembolism: a community-based study in western France. Thrombosis and Haemostasis, 83, 657-660.
71. Okrent, D., Messersmith, R. & Buckman, J. (1991) Transcatheter fibrinolytic therapy and angioplasty for left iliofemoral venous thrombosis. Journal of Vascular and Interventional Radiology, 2, 195-200.
72. Oudega, R., Moons, K. & Hoes, A. (2005) Ruling out deep venous thrombosis in primary care: a simple diagnostic algorithm including D-dimer testing. Thrombosis and Haemostasis, 94, 200-205.
73. Penaloza, A., Verschuren, F., Meyer, G., Quentin-Georget, S., Soulie, C., Thys, F. & Roy, P.-M. (2013) Comparison of the unstructured clinician gestalt, the wells score, and the revised Geneva score to estimate pretest probability for suspected pulmonary embolism. Annals of Emergency Medicine, 62, e2.
74. Pennell, R., Mantese, V. & Westfall, S. (2008) Duplex scan for deep vein thrombosis - defining who needs an examination of the contralateral asymptomatic leg. Journal of Vascular Surgery, 48, 413-416.
75. Perkins, J., Magee, T. & Galland, R. (1996) Phlegmasia caerulea dolens and venous gangrene. British Journal of Surgery, 83, 19-23.
76. Perzborn, E., Heitmeier, S., Laux, V. & Buchmüller, A. (2014) Reversal of rivaroxaban-induced anticoagulation with prothrombin complex concentrate, activated prothrombin complex concentrate and recombinant activated factor VII in vitro. Thrombosis Research, 133, 671-681.
77. Phillips, L. & Sarkar, R. (2007) Molecular characterization of post-thrombotic syndrome. Journal of Vascular Surgery, 45(Suppl. A), A116-A122.
78. Phinikaridou, A., Andia, M., Saha, P., Modarai, B., Smith, A. & Botnar, R. (2013) In vivo magnetization transfer and diffusion-weighted magnetic resonance imaging detects thrombus composition in a mouse model of deep vein thrombosis. Circulation. Cardiovascular Imaging, 6, 433-440.
79. Prandoni, P. (2012) Healthcare burden associated with the post-thrombotic syndrome and potential impact of the new oral anticoagulants. European Journal of Haematology, 88, 185-194.
80. Prandoni, P., Lensing, A., Cogo, A., Cuppini, S., Villalta, S., Carta, M., Cattelan, A., Polistena, P., Bernardi, E. & Prins, M. (1996) The long-term clinical course of acute deep venous thrombosis. The Annals of Internal Medicine, 125, 1-7.
81. Prandoni, P., Villalta, S., Bagatella, P., Rossu, L., Marchiori, A., Picciolo, A., Bernardi, E., Girolami, B., Simioni, P. & Girolami, A. (1997) The clinical course of deep vein thrombosis. Prospective long-term follow-up of 528 symptomatic patients. Haematologica, 82, 423-428.
82. Prandoni, P., Noventa, F., Ghirarduzzi, A., Pengo, V., Bernardi, E., Pesavento, R., Iotti, M., Tormene, D., Simioni, P., Pagnan, A., Santa, A. & Nuova, M. (2007) The risk of recurrent venous thromboembolism after discontinuing anticoagulation in patients with acute proximal deep vein thrombosis or pulmonary embolism. A prospective cohort study in 1, 626 patients. Haematologica, 92, 199-205.
83. Puskás, A., Balogh, Z., Hadadi, L., Imre, M., Orbán, E., Kósa, K., Brassai, Z. & Mousa, S. (2007) Spontaneous recanalization in deep venous thrombosis: a prospective duplex ultrasound study. International Angiology, 26, 53-63.
84. Raju, S. & Neglen, P. (2009) Percutaneous recanalization of total occlusions of the iliac vein. Journal of Vascular Surgery, 50, 360-368.
85. Roberts, L., Patel, R., Chitongo, P., Bonner, L. & Arya, R. (2013) Presenting D-dimer and early symptom severity are independent predictors for post-thrombotic syndrome following a first deep vein thrombosis. British Journal of Haematology, 160, 817-824.
86. Roberts, L., Patel, R., Donaldson, N., Bonner, L. & Arya, R. (2014) Post-thrombotic syndrome is an independent determinant of health-related quality of life following both first proximal and distal deep vein thrombosis. Haematologica, 99, e41-e43.
87. Rodger, M., Kahn, S., Wells, P., Anderson, D., Chagnon, I., Le Gal, G., Solymoss, S., Crowther, M., Perrier, A., White, R., Vickars, L. & Ramsay, T. (2008) Identifying unprovoked thromboembolism patients at low risk for recurrence who can discontinue anticoagulant therapy. Canadian Medical Association Journal, 179, 417-426.
88. Saha, P., Andia, M., Modarai, B., Blume, U., Humphries, J., Patel, A., Phinikaridou, A., Evans, C., Mattock, K., Grover, S., Ahmad, A., Lyons, O., Attia, R., Renné, T., Premaratne, S., Wiethoff, A., Botnar, R., Schaeffter, T., Waltham, M. & Smith, A. (2013) Magnetic resonance T1 relaxation time of venous thrombus is determined by iron processing and predicts susceptibility to lysis. Circulation, 128, 729-736.
89. Saunders, J., Arya, P., Abisi, S., Yong, Y., MacSweeney, S., Braithwaite, B. & Altaf, N. (2013) Catheter-directed thrombolysis for iliofemoral deep vein thrombosis. The British Journal of Surgery, 100, 1025-1029.
90. Schiele, F., Ryn, J., Canada, K., Newsome, C., Sepulveda, E., Park, J., Nar, H. & Litzenburger, T. (2013) A specific antidote for dabigatran: functional and structural characterization. Blood, 121, 3554-3562.
91. Schouten, H., Koek, H., Oudega, R., Geersing, G.-J., Janssen, K., van Delden, J. & Moons, K. (2012) Validation of two age dependent D-dimer cut-off values for exclusion of deep vein thrombosis in suspected elderly patients in primary care: retrospective, cross sectional, diagnostic analysis. BMJ, 344, e2985.
92. Schulman, S., Lindmarker, P., Holmstrom, M., Larfars, G., Carlsson, A., Nicol, P., Svensson, E., Ljungberg, B., Viering, S., Nordlander, S., Leijd, B., Jahed, K., Hjorth, M., Linder, O. & Beckman, M. (2006) Post-thrombotic syndrome, recurrence, and death 10 years after the first episode of venous thromboembolism treated with warfarin for 6 weeks or 6 months. Journal of Thrombosis and Haemostasis, 4, 734-742.
93. Schulman, S., Kearon, C., Kakkar, A., Mismetti, P., Schellong, S., Eriksson, H., Baanstra, D., Schnee, J. & Goldhaber, S. (2009) Dabigatran versus warfarin in the treatment of acute venous thromboembolism. New England Journal of Medicine, 361, 2342-2352.
94. Sharifi, M., Mehdipour, M., Bay, C., Smith, G. & Sharifi, J. (2010) Endovenous therapy for deep venous thrombosis: the TORPEDO trial. Catheterization and Cardiovascular Interventions, 76, 316-325.
95. Siau, K., Davies, A. & Laversuch, C. (2010) Is there still a role for computerized strain gauge plethysmography in the assessment of patients with suspected deep vein thrombosis? QJM, 103, 259-264.
96. Siegal, D. (2015) Managing target-specific oral anticoagulant associated bleeding including an update on pharmacological reversal agents. Journal of Thrombosis and Thrombolysis, 39, 395-402.
97. Simes, J., Becattini, C., Agnelli, G., Eikelboom, J., Kirby, A., Mister, R., Prandoni, P. & Brighton, T. (2014) Aspirin for the prevention of recurrent venous thromboembolism: the INSPIRE collaboration. Circulation, 130, 1062-1071.
98. Siragusa, S., Malato, A., Saccullo, G., Iorio, A., Di Ianni, M., Caracciolo, C., Coco, L., Raso, S., Santoro, M., Guarneri, F., Tuttolomondo, A., Pinto, A., Pepe, I., Casuccio, A., Abbadessa, V., Licata, G., Battista Rini, G., Mariani, G. & Di Fede, G. (2011) Residual vein thrombosis for assessing duration of anticoagulation after unprovoked deep vein thrombosis of the lower limbs: the extended DACUS study. American Journal of Hematology, 86, 914-917.
99. Spencer, F., Emery, C., Joffe, S., Pacifico, L., Lessard, D., Reed, G., Gore, J. & Robert, J. (2009) Incidence rates, cllinical profile, and outcomes of patients with venous thromboembolism. The Worcester VTE Study. Journal of Thrombosis and Thrombolysis, 28, 401-409.
100. Stein, P., Chenevert, T., Fowler, S., Goodman, L., Gottschalk, A., Hales, C., Hull, R., Jablonski, K., Leeper, Jr, K.V. & Naidich, D. (2010) Annals of internal medicine gadolinium-enhanced magnetic resonance angiography for pulmonary embolism. Annals of Internal Medicine, 152, 434-443.
101. Strothman, G., Bleba, J., Fowl, R. & Rosenthal, G. (1994) Contralateral duplex scanning for deep venous thrombosis is unnecessary in patients with symptoms. Journal of Vascular Surgery, 22, 543-547.
102. Tan, M., Mol, G., van Rooden, C., Klok, F., Westerbeek, R., del Sol, A., van de Ree, M., de Roos, A. & Huisman, M. (2014) Magnetic resonance direct thrombus imaging differentiates acute recurrent ipsilateral deep vein thrombosis from residual thrombosis. Blood, 124, 623-627.
103. Ten Cate-Hoek, A., Bouman, A., Joore, M., Prins, M. & Ten Cate, H. (2014) The IDEAL DVT study, individualised duration elastic compression therapy against long-term duration of therapy for the prevention of post-thrombotic syndrome: protocol of a randomised controlled trial. BMJ, 4, e005265.
104. Tosetto, A., Iorio, A., Marcucci, M., Baglin, T., Cushman, M., Eichinger, S., Palareti, G., Poli, D., Tait, R. & Douketis, J. (2012) Predicting disease recurrence in patients with previous unprovoked venous thromboembolism: a proposed prediction score (DASH). Journal of Thrombosis and Haemostasis, 10, 1019-1025.
105. Velde, E., Toll, D., Oudega, R., Stoffers, H., Bossuyt, P., Prins, M., Hoes, A., Moons, K. & Weert, H. (2011) Comparing the diagnostic performance of 2 clinical decision rules to rule out deep vein thrombosis in primary care patients. Annals of Family Medicine, 9, 31-36.
106. Villalta, S., Bagatella, P., Piccioli, A., Lensing, A., Prins, M. & Prandoni, P. (1994) Assessment of validity and reproducibility of a clinical scale for the post-thrombotic syndrome. Haemostasis, 24, 158a.
107. Vymazal, J., Spuentrup, E., Cardenas-Molina, G., Wiethoff, A., Hartmann, M., Caravan, P. & Parsons, E. (2009) Thrombus imaging with fibrin-specific gadolinium-based MR contrast agent EP-2104R: results of a phase II clinical study of feasibility. Investigative Radiology, 44, 697-704.
108. Watson, L., Broderick, C. & Armon, M. (2014) Thrombolysis for acute deep vein thrombosis. Cochrane Database Systematic Review, 1, CD002783.
109. Wells, P., Anderson, D., Bormanis, J., Guy, F., Mitchell, M., Gray, L., Clement, C., Robinson, K. & Lewandowski, B. (1997) Value of assessment of pretest probability of deep-vein thrombosis in clinical management. Lancet, 350, 1795-1798.
110. Wells, P., Anderson, D., Rodger, M., Forgie, M., Kearon, C., Dreyer, J., Kovacs, G., Mitchell, M., Lewandowski, B. & Kovacs, M. (2003) Evaluation of D-dimer in the diagnosis of suspected deep-vein thrombosis. New England Journal of Medicine, 349, 1227-1235.